| NCT Number | NCT07643233 |
| Lead Sponsor | AJU Pharm Co., Ltd. |
| Conditions | Moderate-to-severe Benign Prostatic Hyperplasia (BPH) |
| Enrollment | 36 participants |
| Start Date | 2026-07 |
| Primary Completion | 2026-07 (estimated) |
| Study Completion | 2026-08 (estimated) |
| Updated on ClinicalTrials.gov | 2026-06-11 |